Clinical trial
Mitigating Toxicity of (Neo)Adjuvant Chemotherapy by Applying Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects: the Prospective Randomized eChemoCoach Trial
NCT06424054 is registered in ClinicalTrials.gov with Noordwest Ziekenhuisgroep as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mitigating Toxicity of (Neo)Adjuvant Chemotherapy by Applying Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects: the Prospective Randomized eChemoCoach Trial
- Lead sponsor
- Noordwest Ziekenhuisgroep
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2025
- Completion date
- December 1, 2029
- Enrollment
- 746 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, ehealth, self management, symptom monitoring